EMDB/PDB/SASBDBから引用されている文献のデータベース

キーワード
構造解析手法	All X線回折 NMR 電子顕微鏡小角散乱中性子線回折線維回折粉末回折赤外分光 EPR FRET 理論モデルハイブリッド
著者・登録者
ジャーナル
IF	>30 >20 >10 >5 all

タイトル	Crystallographic fragment screen of the c-di-AMP-synthesizing enzyme CdaA from Bacillus subtilis.
ジャーナル・号・ページ	Acta Crystallogr. ,Sect. F, Vol. 80, Page 200-209, Year 2024
掲載日	2023年3月15日 (構造データの登録日)
著者	Garbers, T. / Neumann, P. / Wollenhaupt, J. / Dickmanns, A. / Weiss, M.S. / Ficner, R.
リンク	Acta Crystallogr. ,Sect. F / PubMed:39177700
手法	X線回折
解像度	1.1 - 2.45 Å
構造データ	PDB-8ofh: Streptococcus pneumoniae CdaA 手法: X-RAY DIFFRACTION / 解像度: 1.64 Å PDB-8ofo: Structure of Enterococcus faecium CdaA 手法: X-RAY DIFFRACTION / 解像度: 2.45 Å PDB-8ogm: Crystal structure of CdaA from Bacillus subtilis 手法: X-RAY DIFFRACTION / 解像度: 1.1 Å PDB-8ogn: PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry A09 手法: X-RAY DIFFRACTION / 解像度: 1.29 Å PDB-8ogo: PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry A12 手法: X-RAY DIFFRACTION / 解像度: 1.21 Å PDB-8ogp: PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry B03 手法: X-RAY DIFFRACTION / 解像度: 1.22 Å PDB-8ogq: PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry B06 手法: X-RAY DIFFRACTION / 解像度: 1.42 Å PDB-8ogr: PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry B07 手法: X-RAY DIFFRACTION / 解像度: 1.35 Å PDB-8ogs: PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry B08 手法: X-RAY DIFFRACTION / 解像度: 1.25 Å PDB-8ogt: PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry C04 手法: X-RAY DIFFRACTION / 解像度: 1.5 Å PDB-8ogu: PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry C07 手法: X-RAY DIFFRACTION / 解像度: 1.41 Å PDB-8ogv: PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry C08 手法: X-RAY DIFFRACTION / 解像度: 1.25 Å PDB-8ogw: PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry D02 手法: X-RAY DIFFRACTION / 解像度: 1.17 Å PDB-8ogy: PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry D04 手法: X-RAY DIFFRACTION / 解像度: 1.23 Å PDB-8ogz: PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry D06 手法: X-RAY DIFFRACTION / 解像度: 1.14 Å PDB-8oh0: PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry D08 手法: X-RAY DIFFRACTION / 解像度: 1.27 Å PDB-8oh1: PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry E04 手法: X-RAY DIFFRACTION / 解像度: 1.22 Å PDB-8ohb: PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry E08 手法: X-RAY DIFFRACTION / 解像度: 1.11 Å PDB-8ohc: PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry E12 手法: X-RAY DIFFRACTION / 解像度: 1.17 Å PDB-8ohe: PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry F03 手法: X-RAY DIFFRACTION / 解像度: 1.15 Å PDB-8ohf: PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry F04 手法: X-RAY DIFFRACTION / 解像度: 1.22 Å PDB-8ohg: PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry F09 手法: X-RAY DIFFRACTION / 解像度: 1.25 Å PDB-8ohh: PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry G05 手法: X-RAY DIFFRACTION / 解像度: 1.3 Å PDB-8ohj: PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry G08 手法: X-RAY DIFFRACTION / 解像度: 1.22 Å PDB-8ohk: PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry H01 手法: X-RAY DIFFRACTION / 解像度: 1.26 Å PDB-8ohl: PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry H09 手法: X-RAY DIFFRACTION / 解像度: 1.29 Å PDB-8oho: PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry H11 手法: X-RAY DIFFRACTION / 解像度: 1.32 Å PDB-9g0g: BsCdaA in complex with Compound 7 手法: X-RAY DIFFRACTION / 解像度: 1.7 Å
化合物	ChemComp-HOH: WATER ChemComp-P4G: 1-ETHOXY-2-(2-ETHOXYETHOXY)ETHANE / ジエチレングリコ-ルジエチルエ-テル化合物画像なし ChemComp-U8O: Unknown entry ChemComp-MG: Unknown entry / マグネシウムジカチオン ChemComp-TJ1: 3-(propan-2-yl)-1,2,4-oxadiazol-5(4H)-one ChemComp-SYG: 2-[(1~{S})-1-azanylpropyl]phenol / 2-[(S)-1-アミノプロピル]フェノ-ル ChemComp-R8P: (1S)-1-(4-nitrophenyl)ethan-1-ol 化合物画像なし ChemComp-UIS: Unknown entry ChemComp-T9S: ethyl 1,3-dihydro-2H-pyrrolo[3,4-c]pyridine-2-carboxylate ChemComp-R8S: 2-hydrazinyl-4-methoxypyrimidine 化合物画像なし ChemComp-VN9: Unknown entry ChemComp-R8V: (3S)-3-hydroxy-2-methyl-2,3-dihydro-1H-isoindol-1-one ChemComp-SY4: ~{N}-[5-azanyl-2,4-bis(fluoranyl)phenyl]propane-1-sulfonamide ChemComp-RQD: methyl 4-fluoro-L-phenylalaninate / 4-フルオロフェニルアラニンメチル化合物画像なし ChemComp-VNE: Unknown entry 化合物画像なし ChemComp-VNO: Unknown entry 化合物画像なし ChemComp-VNV: Unknown entry 化合物画像なし ChemComp-UHL: Unknown entry ChemComp-SYV: 6-azanyl-3-methyl-1,3-benzoxazol-2-one ChemComp-RAY: N-(3-fluorophenyl)-2-(2-methoxyethoxy)acetamide ChemComp-RB7: N-[(4-bromo-3-methylphenyl)methyl]-2-(methylsulfonyl)ethan-1-amine 化合物画像なし ChemComp-UI4: Unknown entry ChemComp-XY4: N-phenyl-N'-propan-2-ylurea / 1-イソプロピル-3-フェニル尿素 ChemComp-RDJ: N-ethyl-2-{[5-(propan-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl}acetamide 化合物画像なし ChemComp-VOB: Unknown entry 化合物画像なし ChemComp-VOF: Unknown entry ChemComp-TBJ: N-cyclopentyl-N'-{[(2R)-oxolan-2-yl]methyl}urea ChemComp-REG: 1-cyclopentyl-3-[[(2~{S})-oxolan-2-yl]methyl]urea ChemComp-TJ9: ~{N}-[5-(2-azanyl-1,3-thiazol-4-yl)-4-methyl-1,3-thiazol-2-yl]ethanamide ChemComp-DMS: DIMETHYL SULFOXIDE / 2-チアプロパン2-オキシド / DMSO, 沈殿剤YM ChemComp-PEG: DI(HYDROXYETHYL)ETHER / ジエチレングリコ-ル ChemComp-CL*: Unknown entry / クロリド
由来	streptococcus pneumoniae r6 (肺炎レンサ球菌) enterococcus faecium (バクテリア) bacillus subtilis subsp. subtilis str. 168 (枯草菌) bacillus subtilis (枯草菌)
キーワード	TRANSFERASE / diadenylate cyclase / CdaA / Cyclic-di-AMP